Business
Perimeter Showcases Innovative Imaging Technology at Aptitude Health/TME's Fall Summit on Breast Cancer Care
Perimeter Showcases Innovative Imaging Technology at Aptitude Health/TME's Fall Summit on Breast ...
About this update from Perimeter Medical Imaging Ai Inc
[{"type":"text","content":"\n\n\n\n Perimeter Showcases Innovative Imaging Technology at Aptitude Health/TME's Fall Summit on Breast Cancer Care\n \n\n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n \n\n\n\n\n\n Canada NewsWire\n \n\n\n\n\n\n\n\n\n\n\n\n Industry-leading event gathers influential breast care physicians to explore best practices and the future of patient care\n \n\n\n\n\n TORONTO\n \n and\n \n DALLAS\n \n\n ,\n \n\n Sept. 26, 2025\n \n\n /CNW/ -\n \n\n Perimeter Medical Imaging AI\n \n\n , Inc. (TSXV: PINK) (OTCQX: PYNKF) (\"Perimeter\" or the \"Company\"), a commercial-stage medical technology company, announced today that it will be exhibiting at Aptitude Health/TME's Fall Summit,\n \n \"Take the Lead in Breast Cancer Care,\"\n \n in\n \n New Orleans\n \n ,\n \n Sept. 26-27\n \n . The annual summit gathers about 50 of the nation's leading breast cancer physicians for high-level, multi-disciplinary discussions on advancing care for high-risk and newly diagnosed breast cancer patients.\n \n\n \"Perimeter's OCT (optical coherence tomography) technology gives surgeons the ability to visualize margins in the OR. Combined with AI capabilities in our next generation platform, it could mark a major advance in intraoperative care,\" said Perimeter CEO\n \n Adrian Mendes\n \n . \"This intimate forum is a unique opportunity to expose our device to an esteemed group of leading breast cancer physicians and other experts at the forefront of cancer care.\"\n \n\n Perimeter's\n \n\n S-Series OCT\n \n\n received U.S. Food and Drug Administration (\"FDA\") clearance in 2021 under a general imaging indication, and the performance of an AI-assisted version is currently under\n \n\n FDA evaluation\n \n\n specifically for use in intraoperative breast cancer imaging.\n \n\n TME's\n \n Take the Lead in Breast Cancer Care\n \n symposium convenes surgeons, oncologists, pathologists, genetic specialists, and industry for closed-door roundtable discussions and breakout sessions that explore innovative diagnostics and therapeutic discoveries, real-world clinical insights and challenges, a...